{"denoms":[{"counts":[{"groupId":"BG000","value":"11"}],"units":"Participants"}],"groups":[{"description":"All participants enrolled.\n\n5-Azacitidine: Administered on Days 1-7 of each Cycle.\n\nSubcutaneous administration:\n\nTo provide a homogeneous suspension, the contents of the syringe must be re-suspended by inverting the syringe 2-3 times and vigorously rolling the syringe between the palms for 30 seconds immediately prior to administration.\n\nThe 5-azacitidine suspension is administered subcutaneously.\n\nIntravenous Administration:\n\n5-Azacitidine solution is administered intravenously. Administer the total dose over a period of 10-40 minutes.","id":"BG000","title":"All Patients"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","lowerLimit":"56","upperLimit":"85","value":"69"}]}]}],"dispersionType":"FULL_RANGE","paramType":"MEDIAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"5"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"6"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"}]}